HOME
ABOUT US
OUR COMPANY
OUR TEAM
BOARD OF DIRECTORS
INVESTORS
CAREERS
T-GUARD®
CHARACTERISTICS
DEVELOPMENT PLAN
GRAFT-VERSUS-HOST
ADDITIONAL INDICATIONS
EXPANDED ACCESS
A PATIENT’S STORY
NEWS & EVENTS
NEWS
EVENTS
IN THE MEDIA
PUBLICATIONS
PARTNERING
PARTNERING FOR PROGRESS
CONTACT
✕
2013
Filter by
Languages
Skill level
Authors
Show all
All
Press-releases
All
2012
2013
2014
2015
2016
2017
2018
2019
2021
2022
All
MauriceHampsink
18 september 2013
18 september 2013
T-Guard® Receives Orphan Drug Designation for Treatment of GVHD in the US
